Sales Development Representative, Vial

$51-65k

Canada based salary range: $73,425 - $93,581 CAD. Offers Equity

Junior and Mid level

Remote in Canada, US

More information about location

Contact research organization for biotech

Be an early applicant

Contact research organization for biotech

101-200 employees

HealthcareB2BMedTech

Be an early applicant

$51-65k

Canada based salary range: $73,425 - $93,581 CAD. Offers Equity

Junior and Mid level

Remote in Canada, US

More information about location

101-200 employees

HealthcareB2BMedTech

Company mission

To reimagine clinical trials and deliver faster and more efficient trials for sponsors.

Job

Company

Role

Who you are

Primarily responsible for booking meetings with the end goal of moving partners to a Non Disclosure Agreement
Qualifying prospects, producing quality leads for the Vial Sales team
Collaborate with the sales team on account strategy, demand generation activities, and results
Ensure all data is properly maintained and updated in CRM and sales engagement platforms
Stay informed and continuously improve by reading industry-related content, listening to podcasts, and learning from your teammates and peers daily

What the job involves

The Strategic Growth Associate (Sales Development Representative) has a genuine passion for healthcare, sales, strategic thinking, execution, and cross-functional learning
You’ll report to our VP of Business Development
Primarily responsible for booking meetings with the end goal of moving partners to a Non Disclosure Agreement
Qualifying prospects, producing quality leads for the Vial Sales team
Collaborate with the sales team on account strategy, demand generation activities, and results
Ensure all data is properly maintained and updated in CRM and sales engagement platforms
Stay informed and continuously improve by reading industry-related content, listening to podcasts, and learning from your teammates and peers daily

Our take

Clinical trials can decide the financial success for a drug that takes decades to make, as without them the Food and Drug Administration cannot approve it. Vial organizes the trial process, offering three technology platforms for starting up sites, capturing data and recruiting patients.

The problem currently faced by the biotech industry is that clinical trials are slow-moving and capital-intensive. One inefficiency is the specificity required when cherry-picking the right candidates for a drug. Aiding this process, Vial helps companies find patients across any given country and better collect data that can be organized.

With impressive funding at its disposal, one round recently led by General Catalyst, Vial will continue to help simplify an unorganised industry. With investments in this field becoming increasingly active, Vial is well placed to continue its upwards growth.

Freddie

Company Specialist at Welcome to the Jungle

Insights

Top investors

Few candidates hear
back within 2 weeks

10% employee growth in 12 months

Glassdoor (2.5)

Company

Funding (1 round)

Dec 2022

$67m

SERIES B

Total funding: $67m

Company benefits

Unlimited Vacation
Exceptional healthcare, dental, and vision coverage
Paid parental leave
Remote-first culture

Company values

Do it Right - Our goal is to build a generational company. We need to be ruthless about being excellent
Ship It - Move fast. We each operate autonomously within an OKR structure and ultimate vision of the company
Be Intellectually Honest - Be bold, but operate with integrity and transparency
Writing is a Superpower - The best decisions start with a well-framed argument in a document
ABCD (Always Be Connecting Dots) - Relationships are the main driver of performance, not tech
Structure It - We value structured, well developed thinking. Carefully laid out, deeply contemplated and well reasoned cases are incredibly valuable
Have Fun! - If something big happens, you can jump up and down and cheer!

Company HQ

SoMa, San Francisco, CA

Articles

Vial raises $67M for clinical trial tech and more digital health fundings

Vial’s $67M Series B, Tempo’s SPAC Merger, and More Bay Area Tech News

Leadership

Andrew Brackin

(Boardmember & Co-Founder)

Previously served as CRO for Vial. Experience as Early Head of Growth for Newfront and as part of the Founding Team for Jobr for Business.

Simon Burns

(CEO & co-founder)

Previously acted as Senior Product Manager for Chime and as Product Manager for Opendoor. Co-founded Wealthcoin.

Share this job

View 2 more jobs at Vial